Avax Technologies, Inc. is an immuno oncology company focused on developing the next generation of cancer vaccines that maximize antigenicity. Avax is a pioneer in autologous tumor cell vaccines that has developed a vaccine development platform, a proprietary administration regimen and autologous vaccine production process and built a GMP production facility. Avax has late stage cancer vaccines, Ovax and Mvax for ovarian cancer and melanoma, respectively.
Quote | Avax Techs Inc (OTCMKTS:AVXT)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 17,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Avax Techs Inc (OTCMKTS:AVXT)
DeFi Technologies Announces Q1 2022 Financial Results, with Valour Q1 2022 Net Income of $967,666 Canada NewsWire TORONTO , May 17, 2022 /CNW/ - DeFi Technologies Inc. (the " Company " or " DeFi Technologies ") (NEO: DEFI) (GR: RMJR) (OTC: DEF...
Message Board Posts | Avax Techs Inc (OTCMKTS:AVXT)
Subject | By | Source | When |
---|---|---|---|
$AVXT: As of May 25, 2021, TD Ameritrade | Renee | investorshub | 05/01/2021 1:33:06 PM |
Solid Trading Today. Is there any update on | cuckoo 4 cocoa puffs | investorshub | 04/05/2021 7:19:05 PM |
Bought Back In! Word Is Getting Out Regarding | cuckoo 4 cocoa puffs | investorshub | 03/03/2021 9:35:51 PM |
Holy Crap I sold in the 002's!!!!! Damn it | cuckoo 4 cocoa puffs | investorshub | 02/11/2021 6:45:40 PM |
Estimated Study Completion Date: January 2021 | rikic | investorshub | 02/11/2021 6:48:57 AM |
News, Short Squeeze, Breakout and More Instantly...
Avax Techs Inc Company Name:
AVXT Stock Symbol:
OTCMKTS Market:
DeFi Technologies Announces Q1 2022 Financial Results, with Valour Q1 2022 Net Income of $967,666 Canada NewsWire TORONTO , May 17, 2022 /CNW/ - DeFi Technologies Inc. (the " Company " or " DeFi Technologies ") (NEO: DEFI) (GR: RMJR) (OTC: DEF...